As demonstrated, in stable HCC-1 cells with HBO1 shRNA (HBO1-shRNA-1/2, see Fig. 2), activities of caspase-3 (Fig. 3A) and caspase-9 (Fig. 3B) were significantly elevated. This evidence concerns the gene CASP9 and hepatocellular carcinoma.